Mechanisms and Therapeutic Implications of Neuroleptic Atypicality [PDF]
Neuroleptics have proven effective for the overall treatment of schizophrenia. The neuroleptic therapy of schizophrenia, however, has been limited by tardive dyskinesia and by the relative inability of neuroleptics to ameliorate the negative symptoms of ...
Javitt, MD, Daniel C.
core +1 more source
Stratification of the risk of developing tardive drug-induced complications
Tardive drug dystonia / dyskinesia is one of the rare, and at the same time, the most severe motor complications associated with the use of pharmacological drugs. Complex assessment of risk factors for the development of tardive drug-induced side effects
L. A. Khublarova +2 more
doaj
Patient and physician perceptions of the burden of tardive dyskinesia: an international survey. [PDF]
Chepke C +10 more
europepmc +1 more source
Deutetrabenazine and Modified Electroconvulsive Therapy for Tardive Dyskinesia With Recurrent Depression: A Case Report. [PDF]
Wan Z, Li X, Fang Y, Zeng C, Shen M.
europepmc +1 more source
Reversible aripiprazole-induced tardive dyskinesia: a case series from Saudi Arabia and literature review. [PDF]
Alshahrani SM +5 more
europepmc +1 more source
Involuntary Commitment and Forced Psychiatric Drugging in the Trial Courts: Rights Violations as a Matter of Course [PDF]
Gottstein, James B. (Jim)
core +1 more source
Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report. [PDF]
Chen YM, Chang S.
europepmc +1 more source
Plasma Metabolic Characteristics and Potential Biomarker Combinations in Schizophrenia Patients With Tardive Dyskinesia. [PDF]
Lu C +10 more
europepmc +1 more source
Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia. [PDF]
Yu T +10 more
europepmc +1 more source

